SCHEMBL17622892

SCHEMBL17622892

Cn1cc(C2NC(=O)N(CC(=O)O)C2=O)c2ccccc21

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.46
ALDH1A1 P00352 4/20 0.45
USP2 O75604 1/20 0.45
LMNA P02545 6/20 0.45
MAPT P10636 2/20 0.44
HTT P42858 1/20 0.44
POLB P06746 2/20 0.44
CYP1A2 P05177 1/20 0.44
CYP2C9 P11712 1/20 0.44
ADORA3 P0DMS8 1/20 0.44
KMT2A Q03164 2/20 0.43
MEN1 O00255 1/20 0.43
HPGD P15428 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
PTGDR2 Q9Y5Y4 2/20 0.43
CMA1 P23946 2/20 0.43
PKM P14618 1/20 0.40
PPARG P37231 1/20 0.40
NCOA2 Q15596 1/20 0.40
NCOA1 Q15788 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17622894 0.84 POLB (0.51) KDM4EALDH1A1USP2LMNAMAPT
SCHEMBL17622884 0.79 EP300 (0.73) EP300CREBBP
SCHEMBL17623028 0.77 PKM (0.48) KDM4EALDH1A1LMNAMAPTCYP1A2
SCHEMBL17622943 0.77 LMNA (0.66) ALDH1A1LMNAADORA3SMN1; SMN2EP300
SCHEMBL7202789 0.77 LMNA (0.66) ALDH1A1LMNAADORA3SMN1; SMN2EP300
SCHEMBL17622981 0.77 EP300 (0.59) ALDH1A1LMNAADORA3KMT2ASMN1; SMN2
SCHEMBL17610653 0.75 LMNA (0.47) KDM4EALDH1A1LMNAMAPTPOLB
SCHEMBL17623035 0.74 KDM4E (0.46) KDM4EALDH1A1LMNAHTTPOLB
SCHEMBL17622891 0.72 KMT2A (0.52) ALDH1A1USP2LMNAMAPTHTT
SCHEMBL17622814 0.70 LMNA (0.44) KDM4EALDH1A1LMNAMAPTHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016044777-A1 HAT INHIBITORS AND METHODS FOR THEIR USE ABBVIE INC. (US) 2016-03-24 WO disclosed